1-20 of 21
Reed Friend
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Nivolumab As an Adjunctive Therapy in Relapsed Refractory Multiple Myeloma Patients with Sub-Optimal Response to Idecabtagene Vicleucel

Barry Paul, Myra Robinson, James Symanowski, David M Foureau, Sarah Norek, Manisha Bhutani, Christopher Ferreri, Ami P Ndiaye, Jordan Robinson, Shebli Atrash, Cindy Varga, Reed Friend, Mauricio Pineda-Roman, April Smith, Jessica Duda, Lance Cooper, Amani Kitali, Peter M. Voorhees
Journal: Blood
Blood (2024) 144 (Supplement 1): 7027.
https://doi.org/10.1182/blood-2024-208830
Published: 2024
Journal Articles

Efficacy of BCMA T-Cell Engagers (TCE) Vs. Chimeric Antigen Receptor T-Cell Therapy (CAR-T) Following BCMA-Directed Therapies, Relapsed/Refractory Multiple Myeloma: The Chicken or the Egg Dilemma

Jordan Snyder, Nausheen Ahmed, Zahra Mahmoudjafari, Al-Ola Abdallah, Joseph P. McGuirk, Muhammad Umair Mushtaq, Alma Habib, Abdullah Mohammad Khan, Mehak M Laharwal, Prerna Mewawalla, Marshall McKenna, Yun Kyoung Tiger, Hira Shaikh, Andrew Vegel, Emily Struble, Jonathan Lochner, Christopher Strouse, Kimberly M Green, James A Davis, Hamza Hashmi, Shebli Atrash, Reed Friend, Barry Paul
Journal: Blood
Blood (2024) 144 (Supplement 1): 7098.
https://doi.org/10.1182/blood-2024-207398
Published: 2024
Journal Articles

Talquetamab in B Cell Maturation Antigen (BCMA) Exposed Relapsed-Refractory Multiple Myeloma Patients

Hira Shaikh, Jonathan Lochner, Bradley Loeffler, Reed Friend, Alma Habib, Marshall McKenna, Jordan Snyder, James A Davis, Gina Patrus, Rachel Dileo, Prerna Mewawalla, Kimberly M Green, Muhammad Umair Mushtaq, Christopher Strouse, Yun Kyoung Tiger, Al-Ola Abdallah, Nausheen Ahmed, Abdullah Mohammad Khan, Hamza Hashmi, Barry Paul, Shebli Atrash
Journal: Blood
Blood (2024) 144 (Supplement 1): 5170.4.
https://doi.org/10.1182/blood-2024-211018
Published: 2024
Journal Articles

Real-World Safety and Efficacy of Talquetamab for Patients with Heavily Pretreated Relapsed-Refractory Multiple Myeloma

Hira Shaikh, Jonathan Lochner, Bradley Loeffler, Reed Friend, Alma Habib, Marshall McKenna, Jordan Snyder, James A Davis, Gina Patrus, Rachel Dileo, Prerna Mewawalla, Kimberly M Green, Kittika Poonsombudlert, Muhammad Umair Mushtaq, Al-Ola Abdallah, Nausheen Ahmed, Shebli Atrash, Hamza Hashmi, Christopher Strouse, Barry Paul, Abdullah Mohammad Khan, Yun Kyoung Tiger
Journal: Blood
Blood (2024) 144 (Supplement 1): 7860.
https://doi.org/10.1182/blood-2024-210976
Published: 2024
Journal Articles

Talquetamab Bridging: Paving the Way to B-Cell Maturation Antigen (BCMA) CAR-T Cell Therapy in Relapsed/Refractory Multiple Myeloma (RRMM)

Binod Dhakal, Othman S. Akhtar, Andrew J. Cowan, Shambavi Richard, Reed Friend, Matthew J Rees, Patrick Costello, Mariola Vazquez Martinez, Oren Pasvolsky, Charlotte B Wagner, Alexandria Jensen, James A Davis, Ran Reshef, Danai Dima, Rahul Banerjee, Manisha Bhutani, Omar Nadeem, Ricardo D. Parrondo, Lekha Mikkilineni, Shahzad Raza, Prashant Kapoor, Hitomi Hosoya, Saurabh Chhabra, Ariel Grajales-Cruz, Mahmoud R. Gaballa, Shonali Midha, Melissa Alsina, Douglas W. Sborov, Krina K. Patel, Yi Lin, Christopher J Ferreri, Doris K. Hansen, Luciano J. Costa, Surbhi Sidana
Journal: Blood
Blood (2024) 144 (Supplement 1): 931.
https://doi.org/10.1182/blood-2024-202017
Published: 2024
Journal Articles

A Real-World Analysis of the Safety and Efficacy of Teclistamab for Patients with Relapsed/Refractory Multiple Myeloma and Baseline Renal Impairment

Alma Habib, Abdullah Mohammad Khan, Mehak M Laharwal, Prerna Mewawalla, Marshall McKenna, Yun Kyoung Tiger, Hira Shaikh, Christopher Strouse, Kimberly M Green, James A Davis, Hamza Hashmi, Jordan Snyder, Zahra Mahmoudjafari, Muhammad Umair Mushtaq, Nausheen Ahmed, Al-Ola Abdallah, Shebli Atrash, Barry Paul, Reed Friend
Journal: Blood
Blood (2024) 144 (Supplement 1): 7037.
https://doi.org/10.1182/blood-2024-209283
Published: 2024
Journal Articles

Final Results of Phase 1 Clinical Trial of Belantamab Mafodotin Combined with Carfilzomib, Lenalidomide, and Dexamethasone for Multiple Myeloma after One to Three Prior Lines of Therapy

Shebli Atrash, James Symanowski, Sarah Norek, Monica Plott, Cecilia Flynn, Kelly Bumgarner, Darynne Rhinehardt, Xhevahire Begic, Robin Cox, Barry Paul, Cindy Varga, Reed Friend, Christopher Ferreri, Manisha Bhutani, Mauricio Pineda-Roman, Peter M. Voorhees
Journal: Blood
Blood (2024) 144 (Supplement 1): 4751.
https://doi.org/10.1182/blood-2024-205957
Published: 2024
Journal Articles

A Real-World Analysis of the Safety and Efficacy of BCMA-Directed CAR T-Cell Therapy for Patients with Relapsed/Refractory Multiple Myeloma and Baseline Renal Impairment

Alma Habib, Nausheen Ahmed, Abdullah Mohammad Khan, Darryl Chang, Barry Paul, Hira Shaikh, Christopher Strouse, Emily Struble, Andrew Vegel, James A Davis, Kimberly M Green, Hamza Hashmi, Zahra Mahmoudjafari, Muhammad Umair Mushtaq, Joseph P. McGuirk, Al-Ola Abdallah, Shebli Atrash, Reed Friend
Journal: Blood
Blood (2024) 144 (Supplement 1): 2009.
https://doi.org/10.1182/blood-2024-208799
Published: 2024
Journal Articles

Primary Therapy Outcomes By Primary Cytogenetic Subtypes in a Large Cohort of Black Patients with Multiple Myeloma at a Single Center

Semegne Hiruy, Myra Robinson, Shebli Atrash, Barry Paul, Reed Friend, Cindy Varga, Christopher J Ferreri, Mauricio Pineda-Roman, Peter M. Voorhees, Manisha Bhutani
Journal: Blood
Blood (2024) 144 (Supplement 1): 3769.
https://doi.org/10.1182/blood-2024-202137
Published: 2024
Journal Articles

Primary Endpoint Analysis from a Response Adaptive Phase II Clinical Trial of Carfilzomib, Lenalidomide, Dexamethasone Plus Daratumumab (KRd-Dara) in Patients with Newly Diagnosed Multiple Myeloma (NDMM)

Manisha Bhutani, Myra Robinson, Shebli Atrash, Barry Paul, Mauricio Pineda-Roman, David Foureau, Cindy Varga, Reed Friend, Xhevahire Begic, Sarah Norek, Tiffany Drennan, Michelle B Anderson, James Symanowski, Peter M. Voorhees, Saad Z Usmani
Journal: Blood
Blood (2023) 142 (Supplement 1): 3380.
https://doi.org/10.1182/blood-2023-174972
Published: 2023
Journal Articles

Phase II Trial of Elotuzumab in Combination with Carfilzomib, Lenalidomide and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma (RRMM) after One Prior Line of Therapy

Manisha Bhutani, Myra Robinson, Shebli Atrash, David M Foureau, Katherine Rigby, Reed Friend, Barry Paul, James T Symanowski, Lawrence J Druhan, Sarah Norek, Mallory Tucker, Mauricio Pineda-Roman, Peter M. Voorhees, Saad Z. Usmani
Journal: Blood
Blood (2021) 138 (Supplement 1): 2739.
https://doi.org/10.1182/blood-2021-148508
Published: 2021
Journal Articles

Central Memory T-Cell Differentiation Correlates with Depth of Response in Relapsed/Refractory Multiple Myeloma Patients Receiving Elotuzumab in Combination with Carfilzomib, Lenalidomide and Dexamethasone (Elo-KRd)

David M Foureau, Manisha Bhutani, Fei Guo, Kateryna Fesenkova, Shebli Atrash, Reed Friend, Barry Paul, Myra M Robinson, James T Symanowski, Lawrence J Druhan, Mauricio Pineda-Roman, Peter M. Voorhees, Saad Z. Usmani
Journal: Blood
Blood (2021) 138 (Supplement 1): 1585.
https://doi.org/10.1182/blood-2021-152505
Published: 2021
Journal Articles

Response-Adaptive Phase II Study of Daratumumab Combined with Carfilzomib, Lenalidomide and Dexamethasone in Newly Diagnosed Multiple Myeloma

Manisha Bhutani, MD, Monika House, RN, BA, Jiaxian He, MS, Shebli Atrash, David M Foureau, PhD, Barry Paul, MDMS, Reed Friend, MD, James T Symanowski, PhD, Sarah Norek, BSN, RN, Xhevahire Begic, MSPH, Donna Acampora, BSN, RN, Katherine K Farmer, BA, Carrie Ann Syfert, BSN, RN, Mauricio Pineda-Roman, MD, Peter Voorhees, MD, Saad Z. Usmani, MDMBBS,MBA
Journal: Blood
Blood (2020) 136 (Supplement 1): 38–39.
https://doi.org/10.1182/blood-2020-138485
Published: 2020
Journal Articles

Phase I/II Study of Carfilzomib, Ruxolitinib and Low-Dose Dexamethasone for Carfilzomib-Refractory Multiple Myeloma (CarJak)

Shebli Atrash, MD, Myra Robinson, MS, Manisha Bhutani, MD, Jeffrey A. Zonder, Reed Friend, MD, Barry Paul, MD, Daniel Auclair, Jordan Robinsons, Ami P Ndiaye, NP, Kelly Bumgarner, Sarah Norek, James T. Symanowski, PhD, Peter M. Voorhees, MD, Saad Z. Usmani, MDMBBS
Journal: Blood
Blood (2019) 134 (Supplement_1): 5570.
https://doi.org/10.1182/blood-2019-130290
Published: 2019
Journal Articles

Rapid Infusion Daratumumab Is Safe and Well Tolerated in Clinical Practice

Issam S. Hamadeh, PharmD, Justin Arnall, Pharm.D., Ekaterina Kachur, PharmD, Allison Martin, PharmD, Megan Helena Jagosky, MD, Reed Friend, MD, Shebli Atrash, Manisha Bhutani, MD, Peter M. Voorhees, MD, Saad Z. Usmani, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2255.
https://doi.org/10.1182/blood-2018-99-118737
Published: 2018
Journal Articles

Prognostic Significance of Ki67 Expression By Immunohistochemistry (IHC) on Bone Marrow Biopsy in Newly Diagnosed Multiple Myeloma

Myra M Robinson, MSPH, Shebli Atrash, Taylor Brown, BS, MS, Jared G Block, MD, Edward H Lipford, MD, Elton T Smith, MD, Reed Friend, MD, Amanda Aneralla, Alankrita Taneja, MD, Qing Zhang, PhD, David M Foureau, PhD, Chelsea Sprouse, Ami Ndiaye, James T Symanowski, PhD, Belinda Rene Avalos, MD, Edward A Copelan, MD, Peter M. Voorhees, MD, Saad Z Usmani, MD, Manisha Bhutani, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4348.
https://doi.org/10.1182/blood.V130.Suppl_1.4348.4348
Published: 2017
Journal Articles

Effect of Immunomodulatory Drugs (IMiDs) on Immune Effectors after Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma

David M Foureau, PhD, Manisha Bhutani, MD, Qing Zhang, PhD, Myra M Robinson, MSPH, Adina Wynn, Nury M Steuerwald, PhD, Lawrence J Druhan, PhD, Fei Guo, PhD, Katherine Rigby, Mitchell Turner, Reed Friend, MD, Shebli Atrash, Chelsea Sprouse, Ami Ndiaye, James T Symanowski, PhD, Belinda Rene Avalos, MD, Edward A Copelan, MD, Peter M. Voorhees, MD, Saad Z Usmani, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1817.
https://doi.org/10.1182/blood.V130.Suppl_1.1817.1817
Published: 2017
Journal Articles

Validation of Dynamic Biomarker-Based Risk Progression Model for Smoldering Multiple Myeloma

Shebli Atrash, Myra M Robinson, MSPH, Amanda Aneralla, Taylor Brown, BS, MS, Reed Friend, MD, Chelsea Sprouse, Ami Ndiaye, Qing Zhang, PhD, Edward H Lipford, MD, Jared G Block, MD, Elton T Smith, MD, James T Symanowski, PhD, Belinda Rene Avalos, MD, Edward A Copelan, MD, Peter M. Voorhees, MD, Saad Z Usmani, MD, Manisha Bhutani, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1779.
https://doi.org/10.1182/blood.V130.Suppl_1.1779.1779
Published: 2017
Journal Articles

Peripheral Cellular Immunome Reveals Heterogeneity Spanning Myeloma Spectrum Diseases

Manisha Bhutani, MD, David M Foureau, PhD, Qing Zhang, PhD, Myra M Robinson, MSPH, Adina Wynn, Nury M Steuerwald, PhD, Lawrence J Druhan, PhD, Fei Guo, PhD, Katherine Rigby, Mitchell Turner, Reed Friend, MD, Shebli Atrash, Ami Ndiaye, Chelsea Sprouse, James T Symanowski, PhD, Belinda Rene Avalos, MD, Edward A Copelan, MD, Peter M. Voorhees, MD, Saad Z Usmani, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3054.
https://doi.org/10.1182/blood.V130.Suppl_1.3054.3054
Published: 2017
Journal Articles

Phase II Trial Daily Pulse Interleukin-2 Therapy with Famotidine during Marrow and Lymphocyte Recovery in Acute Myeloid Leukemia: LJCC 0605

Reed Friend, MD, Ridas Juskevicius, MD, Lauren Salmon, DO, Hemant S. Murthy, MD, James Xenakis, Adam S. Asch, MD, Paul Walker, MD
Journal: Blood
Blood (2015) 126 (23): 3783.
https://doi.org/10.1182/blood.V126.23.3783.3783
Published: 2015